Literature DB >> 10729296

Late onset lattice corneal dystrophy with systemic familial amyloidosis, amyloidosis V, in an English family.

H S Stewart1, R Parveen, A E Ridgway, R Bonshek, G C Black.   

Abstract

AIMS: To establish a clinical and molecular diagnosis in a family with late onset lattice corneal dystrophy.
METHODS: Linkage analysis, single strand conformation polymorphism (SSCP) analysis, and direct sequencing of genomic DNA were performed. A review of the patients' clinical symptoms and signs was undertaken.
RESULTS: Linkage to chromosome 9q34 was established and a mutation in the gelsolin gene was found in affected individuals. Numerous symptoms experienced by the patients were attributable to this mutation.
CONCLUSION: A diagnosis of amyloidosis type V (familial amyloidosis, Finnish type, FAF/Meretoja syndrome/gelsolin related amyloidosis) was made. This is the first case of amyloidosis type V described in the UK. This emphasises the importance of recognition of the extraocular manifestations of eye disease both in the diagnosis and management of the patient. In addition, these findings can help molecular geneticists in their search for disease-causing mutations.

Entities:  

Mesh:

Year:  2000        PMID: 10729296      PMCID: PMC1723421          DOI: 10.1136/bjo.84.4.390

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  27 in total

1.  Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy.

Authors:  G Boysen; G Galassi; Z Kamieniecka; J Schlaeger; W Trojaborg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-11       Impact factor: 10.154

2.  Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene.

Authors:  C P Maury; J Kere; R Tolvanen; A de la Chapelle
Journal:  FEBS Lett       Date:  1990-12-10       Impact factor: 4.124

3.  Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin.

Authors:  M Haltia; J Ghiso; F Prelli; G Gallo; S Kiuru; H Somer; J Palo; B Frangione
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

4.  Trace polypeptides in cellular extracts and human body fluids detected by two-dimensional electrophoresis and a highly sensitive silver stain.

Authors:  C R Merril; R C Switzer; M L Van Keuren
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome.

Authors:  J Meretoja
Journal:  Ann Clin Res       Date:  1969-12

6.  Clinical features of a newly recognized type of lattice corneal dystrophy.

Authors:  T Hida; K Tsubota; K Kigasawa; H Murata; T Ogata; S Akiya
Journal:  Am J Ophthalmol       Date:  1987-09-15       Impact factor: 5.258

7.  Three forms of dominant amyloid neuropathy.

Authors:  G H Sack; K W Dumars; K S Gummerson; A Law; V A McKusick
Journal:  Johns Hopkins Med J       Date:  1981-12

8.  Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin.

Authors:  C P Maury; M Baumann
Journal:  Biochim Biophys Acta       Date:  1990-11-14

9.  Meretoja syndrome. Lattice dystrophy of the cornea with hereditary generalized amyloidosis.

Authors:  P C Donders; L J Blanksma
Journal:  Ophthalmologica       Date:  1979       Impact factor: 3.250

10.  Histopathologic and immunochemical features of lattice corneal dystrophy type III.

Authors:  T Hida; A D Proia; K Kigasawa; F P Sanfilippo; J L Burchette; S Akiya; G K Klintworth
Journal:  Am J Ophthalmol       Date:  1987-09-15       Impact factor: 5.258

View more
  9 in total

Review 1.  Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention.

Authors:  James P Solomon; Lesley J Page; William E Balch; Jeffery W Kelly
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-02-24       Impact factor: 8.250

2.  Clinical features and haplotype analysis of newly identified Japanese patients with gelsolin-related familial amyloidosis of Finnish type.

Authors:  Makiko Taira; Hiroyuki Ishiura; Jun Mitsui; Yuji Takahashi; Toshihiro Hayashi; Jun Shimizu; Takashi Matsukawa; Naoko Saito; Kazumasa Okada; Sadatoshi Tsuji; Hiromasa Sawamura; Shiro Amano; Jun Goto; Shoji Tsuji
Journal:  Neurogenetics       Date:  2012-05-24       Impact factor: 2.660

3.  Exome sequencing establishes a gelsolin mutation as the cause of inherited bulbar-onset neuropathy.

Authors:  James B Caress; Janel O Johnson; Yevgeniya A Abramzon; Gregory A Hawkins; J Raphael Gibbs; Elizabeth A Sullivan; Chamanpreet S Chahal; Bryan J Traynor
Journal:  Muscle Nerve       Date:  2017-03-23       Impact factor: 3.217

Review 4.  The IC3D classification of the corneal dystrophies.

Authors:  Jayne S Weiss; H U Møller; Walter Lisch; Shigeru Kinoshita; Anthony J Aldave; Michael W Belin; Tero Kivelä; Massimo Busin; Francis L Munier; Berthold Seitz; John Sutphin; Cecilie Bredrup; Mark J Mannis; Christopher J Rapuano; Gabriel Van Rij; Eung Kweon Kim; Gordon K Klintworth
Journal:  Cornea       Date:  2008-12       Impact factor: 2.651

5.  Analysis of gelsolin expression pattern in developing chicken embryo reveals high GSN expression level in tissues of neural crest origin.

Authors:  Antonina Joanna Mazur; Gabriela Morosan-Puopolo; Aleksandra Makowiecka; Maria Malicka-Błaszkiewicz; Dorota Nowak; Beate Brand-Saberi
Journal:  Brain Struct Funct       Date:  2014-10-29       Impact factor: 3.270

6.  Clinical, histopathological, and in silico pathogenicity analyses in a pedigree with familial amyloidosis of the Finnish type (Meretoja syndrome) caused by a novel gelsolin mutation.

Authors:  Jesus Cabral-Macias; Leopoldo A Garcia-Montaño; Mario Pérezpeña-Díazconti; Marisa-Cruz Aguilar; Guillermo Garcia; Carlos I Vencedor-Meraz; Enrique O Graue-Hernandez; Oscar F Chacón-Camacho; Juan C Zenteno
Journal:  Mol Vis       Date:  2020-05-02       Impact factor: 2.367

7.  Clinical Features and Brain MRI Findings in Korean Patients with AGel Amyloidosis.

Authors:  E Nae Cheong; Wooyul Paik; Young Chul Choi; Young Min Lim; Hyunjin Kim; Woo Hyun Shim; Hyung Jun Park
Journal:  Yonsei Med J       Date:  2021-05       Impact factor: 2.759

8.  Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study.

Authors:  Eeva-Kaisa Schmidt; Tuuli Mustonen; Sari Kiuru-Enari; Tero T Kivelä; Sari Atula
Journal:  Orphanet J Rare Dis       Date:  2020-01-17       Impact factor: 4.123

9.  Analyses Mutations in GSN, CST3, TTR, and ITM2B Genes in Chinese Patients With Alzheimer's Disease.

Authors:  Yaling Jiang; Bin Jiao; Xinxin Liao; Xuewen Xiao; Xixi Liu; Lu Shen
Journal:  Front Aging Neurosci       Date:  2020-09-10       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.